Transaction · 0001062993-25-003241

ROBINS CHAD M

ROBINS CHAD M, CHAIR, reported a transaction classified as exercise at Adaptive Biotechnologies Corp involving 186080.000000 shares for an estimated $1176025.60. Reported holdings after the transaction were 2762781.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCHAIR
ADPTAdaptive Biotechnologies Corp
Filing timeFeb 22
Trade dateFeb 19, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ADPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ADPT since 2025-02-22Filed 560 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001062993-25-003241
Common Stock
Transaction date
Feb 19, 2025
Filed Feb 22, 2025, 12:28 AM · 3d delay
Shares
186k sh
$632 per share
Estimated value
$117M
Computed from shares × price
Holdings after
2.76M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and Chairman

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2024. The option would have expired on June 9, 2025.

  2. F2

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.67, inclusive. The reporting person undertakes to provide to…

  3. F3

    The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.30 to 8.69, inclusive. The reporting person undertakes to provide to…

  4. F4

    The option is fully vested and exercisable.

Original filing · 0001062993-25-003241
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ADPT